251 related articles for article (PubMed ID: 26100350)
1. Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.
Johal B; Murphy S; Tuohy J; Marshall J
Adv Ther; 2015 Jun; 32(6):567-79. PubMed ID: 26100350
[TBL] [Abstract][Full Text] [Related]
2. An innovative corticosteroid/long-acting β
Usmani O; Roche N; Marshall J; Danagher H; Price D
Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
[No Abstract] [Full Text] [Related]
3. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
Van Holsbeke C; De Backer J; Vos W; Marshall J
Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
7. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
McCabe JC; Koppenhagen F; Blair J; Zeng XM
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
[TBL] [Abstract][Full Text] [Related]
8. Budget impact analysis of a fixed-dose combination of fluticasone propionate and formoterol fumarate (FP/FORM) in a pressurized metered-dose inhaler (pMDI) for asthma.
Dunlop W; Heron L; Fox G; Greaney M
Adv Ther; 2013 Oct; 30(10):933-44. PubMed ID: 24194361
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
Kappeler D; Sommerer K; Kietzig C; Huber B; Woodward J; Lomax M; Dalvi P
Respir Med; 2018 May; 138():107-114. PubMed ID: 29724381
[TBL] [Abstract][Full Text] [Related]
10. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Murnane D; Martin GP; Marriott C
Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
[TBL] [Abstract][Full Text] [Related]
11. Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β
Price DB; Carter V; Martin J; Gardener EA; Skinner D; Yang S; Hoffman M; Willis JC; Cooper AJ
Drugs; 2020 Jan; 80(1):47-60. PubMed ID: 31749061
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
Cripps A; Riebe M; Schulze M; Woodhouse R
Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
[TBL] [Abstract][Full Text] [Related]
13. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
[TBL] [Abstract][Full Text] [Related]
14. Plume temperature emitted from metered dose inhalers.
Brambilla G; Church T; Lewis D; Meakin B
Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.
Price DB; Williams AE; Yoxall S
Respir Res; 2007 Jul; 8(1):46. PubMed ID: 17610727
[TBL] [Abstract][Full Text] [Related]
18. Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study.
Bousquet J; Barnes N; Gibbs M; Gul N; Tomkins SA; Zhou X; Cho YJ; Park HS; Busse W; Zhong N
BMC Pulm Med; 2017 Apr; 17(1):75. PubMed ID: 28454528
[TBL] [Abstract][Full Text] [Related]
19. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
[TBL] [Abstract][Full Text] [Related]
20. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
